Covalon Technologies (OTCMKTS:CVALF – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.02 by $0.05, Zacks reports. Covalon Technologies had a net margin of 5.05% and a return on equity of 5.77%.
Covalon Technologies Stock Down 0.8%
OTCMKTS:CVALF opened at $1.66 on Thursday. Covalon Technologies has a fifty-two week low of $1.16 and a fifty-two week high of $1.74. The stock has a market cap of $45.71 million, a PE ratio of 41.39 and a beta of 0.59. The firm’s fifty day simple moving average is $1.57 and its 200-day simple moving average is $1.45.
Covalon Technologies Company Profile
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
Recommended Stories
- Five stocks we like better than Covalon Technologies
- Is Quantinuum Emerging as a Leader in the Quantum Race?
- J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
